NIH-funded research R01 grant

Branched-chain amino acids and preventing fat buildup in muscle

Official title: Keeping fat out of muscle - Role of Branched Amino AcidsAmino Acids in Insulin Resistance

Funded at University of Pennsylvania · NIH-11170710 · Data updated 2026-11-12

Looks at whether boosting the body's breakdown of branched-chain amino acids can lower muscle fat and help people with insulin resistance or type 2 diabetes.

More Insulin Resistance research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJuly 1, 2018
Project endAugust 31, 2027
Funding year2025
Award (this year)$735,693
NIH project number5R01DK114103-07
Project IDNIH-11170710 on NIH RePORTER

Who could benefit from this research

Could help

Adults with insulin resistance, prediabetes, or type 2 diabetes who can attend visits for blood tests and muscle/vascular measurements would be the most relevant candidates.

Less likely to help

People without insulin resistance or diabetes, or those with health issues unrelated to BCAA metabolism, are unlikely to see direct benefit from this project.

What this research studies

You may have heard that certain amino acids called branched-chain amino acids (BCAAs) are higher in people with insulin resistance and type 2 diabetes. This work uses animal models and laboratory tests to see how turning on BCAA breakdown (with molecules like BT2) changes blood vessel behavior, blood pressure, and how muscle takes up glucose. The team links those lab findings to human data on BCAA levels to see if the same mechanisms apply in people. If human-facing tests are included, they would involve blood measurements, muscle fat or vascular tests, and glucose/insulin measurements.

Why it matters

Potential benefit: If successful, this could lead to new treatments that reduce muscle fat and improve blood sugar control for people with insulin resistance or type 2 diabetes.

How similar studies have gone: Mouse studies show that activating BCAA breakdown with BT2 improves insulin resistance, but human testing and translation remain largely unproven.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Arany, Zoltan P — University of Pennsylvania
  • Study coordinator: Arany, Zoltan P

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.